Quantitative Evaluation of Drug Distribution in Tablets of Various Structures via Raman Mapping by Farkas, Attila et al.
1Quantitative Evaluation of Drug Distribution in Raman Maps 2018 62 1
Quantitative Evaluation of Drug 
Distribution in Tablets of Various 
Structures via Raman Mapping
Attila Farkas1*, Brigitta Nagy1, György Marosi1
Received 11 October 2016; accepted 31 January 2017
Abstract
Hyperspectral imaging was applied to provide quantitative 
spatial information about pharmaceutical samples. The aim 
was to characterize the distribution of active pharmaceutical 
ingredient (API) in manufactured samples quantitatively. Two 
kind of API, imipramine and spironolactone were applied in 
three conventional and two continuous processing technolo-
gies. The homogeneity of distributions of 10% API was deter-
mined through Raman maps applying macropixel analysis 
method. Non-overlapping macropixel analysis (Poole-index) 
and calculation of distributional homogeneity indices (DHIs) 
were compared as a measure of homogeneity. Non-overlapping 
macropixel approach proved to be more sensible than DHI 
evaluation. For enhancing efficacy of DHI we suggest a cor-
rection by weighting scores and considering relative standard 
deviations. This way the capability of DHI can be improved 
significantly. The very slight differences between the continu-
ous methods (the homogeneity of which are much higher than 
that of conventional technologies) could be quantified.
Keywords
Raman mapping, pharmaceuticals, homogeneity, macropixel 
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1 Introduction
Chemical imaging is progressively becoming one of the best 
available techniques to study samples in solid form in a non-de-
structive way [1]. The vibrational spectroscopy such as Raman 
or NIR is potentially useful to provide qualitative [2] and quan-
titative [3-6] information about the studied substances. In addi-
tion, the application of imaging procedure allows us to obtain 
a number of local, pixel-like data in lateral or even vertical 
directions. This approach has become favoured and increas-
ingly preferred in the field of material characterization. The 
pharmaceutical industry brings the Raman imaging into focus 
due to its advantages in local determination of chemical and 
physical characteristics along the original and generic research 
and development. Numerous papers have reported that this 
technique is well suitable for analysing polymorphic forms [7], 
exploring relationship of the ingredients or determining the 
composition of counterfeits [8, 9]. There is a need for extend-
ing this method to investigate the distributional homogeneity 
of blends. During manufacturing processes the proper homo-
geneity has a key role, which determines important properties 
of the end product. For instance, the inappropriate distribution 
leads to lower mechanical strength of tablets, diverse stabilities 
or unacceptable disintegration time. The inhomogeneity of the 
active pharmaceutical ingredient (API) can lead to inacceptable 
content uniformity.
The analysis of a Raman map results in huge amount of 
(semi)quantitative values ordered in a two-dimensional way 
presenting the distribution of a desired component [1, 10]. The 
elements of the map create a histogram and the fitted proba-
bility distribution is characterized by standardized moments 
(mean, standard deviation, skewness, curtosis). Amigo [11] 
presented in a study the weakness of these statistics demon-
strating how misleading can be their usage on a hyperspectral 
image and that none of them is sufficient by itself to describe 
the homogeneity properly. On these grounds it seems to be not 
advisable to make any conclusion regarding the sample homo-
geneity. A more rational way is to compare the maps of real 
samples to a perfectly homogeneous ideal sample. Common 
definition of a perfectly random mixture defines the probability 
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for finding a particle of a constituent identical at all points in 
the mixture [12]. Unlike a liquid mixture, the pixels of a Raman 
image in solid sample differ from each other depending on the 
particle size of the component. It is feasible to construct an arti-
ficial map from the real distribution considering its randomly 
distributed pixels homogeneous. The most adjacent pixels can 
be clustered and assessed as a macropixel. This approach called 
macropixel analysis has been already used for characterizing 
tablets and capsules in NIR-CI [13].The term macropixel refers 
to a square cluster of pixels with an intensity value equal to the 
average or the standard deviation value of the included pixels 
[13]. The quantitative analyses of the macropixels enable to 
assess spatial characteristics of drug products and pharmaceu-
tical blends. Thus the macropixel analysis provides a quantita-
tive way to evaluate the distributional homogeneity. 
Further objective measures have been developed in recent 
years [14-16]. Rosas et al. [14] considered Poole-index as 
the most adaptable index for the hyperspectral imaging. They 
binarized at first the studied map using arbitrary threshold and 
worked with non-overlapping macropixels. Sacre et al. [15] 
developed another criterion called Distributional Homogeneity 
Index (DHI). This method is based on the approach of the 
Continuous-Level Moving Block (CLMB) [13]. Unlike 
non-overlapping macropixels, this method initially searches 
all macropixels of size 2×2 pixels then evaluates them. In the 
next step the macropixel size is increased. The method pro-
ceeds until the total map size is reached. Linear relationship 
has been observed between DHI values and content unifor-
mity values [15]. For certain samples these methods proved to 
be very suitable for the purposes, however for other samples 
such approaches are not discriminative enough. For instance, 
the homogeneity of samples can be set to rank order according 
to Poole-index using one macropixel size. However, it is not 
clear how to rank the samples if the Poole-indices show differ-
ent order at other macropixel sizes. The DHI values can dis-
criminate the homogeneities only if the pixel values form very 
similar Gaussian distributions (in the cases of different batches 
of a product) but it is not clear what to do if this criterion is 
not fulfilled? Furthermore, comparison of two methods has not 
been published yet. This paper aims to assess the homogeneity 
of samples of different drug distribution (due to different man-
ufacturing methods) utilizing data collected from Raman maps. 
2 Materials and methods
2.1 Samples
The samples used for obtaining the Raman mapping datasets 
were described in two published papers [17, 18]. The model 
drugs (imipramine and spironolactone) were applied in phar-
maceutics manufactured differently. Each solid sample con-
tained 10% of active pharmaceutical ingredient (API). The 
samples containing imipramine hydrochloride (IMP, antide-
pressant classified as BCS I, provided by EGIS Pharmaceuticals 
Plc., Budapest, Hungary) with a particle size of 100 µm were 
prepared by three kind of manufacturing technologies: direct 
tabletting (D), fluid-bed granulation by water (F-W) and high-
shear granulation with water (HS-W) [17]. Further ingredients 
were microcrystalline cellulose (FMC BioPolymer, Princeton, 
USA), maize starch (Colorcon, West Point, USA), hydroxy-
propyl-methyl-cellulose (Shin-Etsu, Tokyo, Japan) binder 
and magnesium stearate (Faci Spa, Carasco, Italy) lubricant. 
The mean particle sizes were 100, 65, 60 and 10 µm, respec-
tively. The samples containing spironolactone (SPL, potas-
sium sparing diuretic Sigma-Aldrich, Budapest, Hungary) of 
poor water solubility (28 µg/mL, BCS II) were produced by 
electrospinning and melt-extrusion methods. Polyvinyl capro-
lactame–polyvinyl acetate–polyethylene glycol graft copo-
lymer (Soluplus, molecular weight = ∼118,000 Da, BASF, 
Ludwigshafen, Germany) was selected as matrix polymer and 
applied in the procedure described recently [18].
2.2 Raman measurements
Raman spectra were collected using a Horiba Jobin–Yvon 
LabRAM (Longjumeau, France) system coupled with an exter-
nal diode laser source (785 nm, 80 mW) and an Olympus BX-40 
optical microscope. The tablets containing imipramine were 
mapped with objectives of 10× and 100× magnification apply-
ing 10 μm and 2 μm step sizes respectively. The acquisition time 
of a single spectrum was 30 s in each experiment and two spec-
tra were averaged at a time. The measured area, when the 10× 
objective was used, varied from 28 × 28 to 33 × 33 pixels. Maps 
recorded with the 100× objective consisted of 60 × 60 pixels. 
In the case of materials containing spironolactone low-resolu-
tion maps were measured using 10× magnification. These elec-
trospun and melt-extruded (SPL) samples were analysed with 
50 μm step size. The measurement per sample was performed 
from 24 × 24 points and three spectra of 30 s were averaged 
per point. In each case the component concentrations were esti-
mated with the classical least squares (CLSs) method [19] using 
the reference spectra of the pure components collected on the 
same device under the same conditions. Visualized score maps 
were created with LabSpec 5.41 (Horiba Jobin–Yvon). These 
scores were applied for macropixel analysis.
2.3 Macropixel analysis
The pixels can be assessed by macropixel analysis on a 
two-dimensional image. The analysis can be performed using 
Discrete-Level Tiling (DLT) method with non-overlapping 
tiles or Continuous-Level Moving Block (CLMB) method with 
overlapping macropixels. Along the procedures the macropixel 
size has to be increased step-by-step. The macropixel sizes 
are strictly limited in DLT defining divisors of the total map 
size. In case of CLMB the macropixel size can be increased 
by 1 pixel on each step until the whole distribution map size is 
reached. In both cases a randomized distribution map, created 
3Quantitative Evaluation of Drug Distribution in Raman Maps 2018 62 1
by random mixing of the original distributional map (in order 
to model the perfect homogeneous distribution), is needed to 
assess simultaneously. The original images can be compared to 
the randomized map.
3 Results and discussions
The distributions of drug in IMP-containing samples are 
shown on the Fig. 1.
Significant differences can be encountered, already after 
visual inspection, in the Raman maps of the tablets manufac-
tured different ways. The maps prepared by 10× magnification 
(Fig 1.a-c) show similar distribution as the high-resolution 
maps (Fig 1.d-f). On the maps of D tablet (prepared by direct 
tableting) discrete particles can be seen. In the F-W tablet 
(granulated in fluid bed before tableting) larger aggregated 
particles are at the edge of the maps and API-free (black) areas 
can be found too.
In contrast, the Raman maps taken of the HS-W sample 
(granulated in high shear mixer) indicates higher homogeneity, 
although there was not enough time to dissolve IMP entirely 
in the granulating liquid (contour of the particles remained 
visible). Fig. 2 depicts the SPL distributions in extruded 
(Fig. 2.a) and electrospun (Fig. 2.b) samples.
These images show much better distribution comparing to 
the IMP samples. All these subjective impressions should be 
demonstrated with objective calculated measures. For this pur-
pose, two evaluation methods were used for assessing sample 
homogeneities.
a) b)
c) d)
e) f)
Fig. 1 Spatial distribution of IMP in tablets manufactured by a) direct tabletting (D) b) high-shear granulation with water (HS-W), and c) fluid-bed granulation 
with water (F-W) as determined by low-resolution (10× objective) maps where the black area indicates the lack of API and the white area shows its high 
concentration level. Similar but high-resolution (100× objective) maps are shown in d) D, e) HS-W and f) F-W images
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3.1 Homogeneity evaluation based on the PooleIndex
At first non-overlapping macropixels were generated from 
the CLS-score maps. The low-resolution IMP maps were pre-
pared with various map size (as written in Section 2.2). In the 
case of D tablets the increasing macropixel size of 2, 4, 7 and 14 
pixels (at the edge of macropixels) was set for a map of 28×28 
pixels (shown in Fig. 1). Maps of 32×32 pixels relate to HS-W 
and F-W tablets (Fig. 1). The divisors of such map size were 2, 
4, 8 and 16 pixels. In the case of SPL maps (Fig. 2) macropixels 
with divisors of 2, 3, 4, 6, 8 and 12 pixels were used on the map 
size of 24×24 pixels. Such approach has been applied for the 
high-resolution maps (Fig. 1 d, e and f) as well, in which cases 
the 60×60 pixels were retained. The same non-overlapping 
macropixels have been also created on the randomized maps. 
In the next step the global mean standard deviation (GMSD) of 
the original and randomized image for macropixels was calcu-
lated [20] according to Eq. (1)-(3).
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where  is the standard deviation of the concentration in jth mac-
ropixel; is the ith element of the jth macropixel; n is macropixel 
size; m is the number of macropixels on the sample map (SM) 
and the randomized map (RM).
The GMSD value for real map and the GMSD for the 
randomized map was divided and then multiplied by 100 to 
obtain the percentage homogeneity (H%Poole) in the Poole 
index according to Eq. (3). The Figs. 3 and 4 demonstrate the 
calculated H%Poole changings on the low-resolution and the 
high-resolution maps of IMP, respectively.
In the case of Raman maps with 10× magnification a rel-
ative macropixel area was needed to determine relating the 
current macropixel size to the selected total map size due to 
its variation from sample to sample. This diagram indicates the 
markedly worse homogeneity of F-W comparing to the other 
samples. However, no remarkable difference could be observed 
between the D and HS-W. In contrast to these low-resolution 
maps, the distribution maps prepared by 100× magnification 
a) b)
Fig. 2 Spatial distribution of SPL in the a) extruded and b) electrospun samples
(1)
(2)
(3)
Fig. 3 Percentage homogeneity of Poole-index on the low-resolution 
maps (10× magnification) of different manufactured tablets: 
D -direct compression, HS-W -high-shear granulation by water and 
F-W -fluid-bed granulation by water
Fig. 4 Percentage homogeneity of Poole-index on the high-resolution maps 
(100× magnification) of different manufactured tablets: D -direct compression, 
HS-W -high-shear granulation by water and F-W -fluid-bed granulation by water
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and lower step size has revealed much more relevant differ-
ences between the tablets. The homogeneity curve indicates 
that HS-W sample is superior to D sample at each macropixel 
size. The F-W has still lower H%Poole values than the other two 
cases confirming less homogeneity of API within that tablet.
The similarly calculated H%Poole indices for SPL samples 
are collected in Table 1. In samples manufactured by contin-
uous technologies the homogeneity proved to be spectacularly 
enhanced. The indices at each macropixel size exceeded 90% 
in both technologies, which is considered homogeneous at 
the applied magnification. This 90% is achieved in both cases 
already at macropixel size 2 pixels, which means that any kind 
of inhomogeneity is lower than 1 pixel.
Table 1 Percentage homogeneity of Poole-index in SPL samples prepared by 
extruded and elctrospun technologies depending on the applied macropixel size
Macropixel size
H%Poole for SPL
Extruded Electrospun
2 100.1 91.4
3 98.7 94.1
4 98.0 95.6
6 98.7 96.8
8 98.6 98.6
12 99.2 99.6
24 100 100
3.2 Homogeneity evaluation based on the 
Distributional Homogeneity Index
DHIs were calculated for the same maps according to 
Eq. (4)-(6)
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where SDj
M  is the standard deviation of the mean concentra-
tion while the macropixel size is m; s is the map size;  m is mac-
ropixel size;  k  is the number of macropixels  (k = (s − m + 1)2); 
cim  is the mean value in  ith macropixel with m macropixel 
size; cm  is the mean value of cim ; AUC is the sum of stan-
dard deviations with different macropixel sizes (area under the 
curve) on the sample map (SM) and the randomized map (RM).
Selecting proper map size is unnecessary for these calcu-
lations in accordance with the approach of CLMB. However, 
due to better comparability the same map sizes were kept that 
have been used for GMSD calculations. DHI as a character-
istic measure for the homogeneity has been calculated for 
the examined samples. The lower values in Table 2 represent 
higher homogeneity. The F-W sample shows the largest DHI 
values, which indicates poor homogeneity (in accordance with 
H%Poole calculations). However, in case of high-resolution 
maps the order of homogeneity differs from that of given by 
the Poole-index.
Table 2 Distributional homogeneity indices (DHI) in Raman distribution 
maps of the different manufactured samples
API
Manufacturing 
technologies
Objective DHI
Std. 
dev.
Imipramine 
(IMP)
direct compression (D)
10× 3.8 0.4
100× 5.4 0.4
fluid-bed granulation  
with water (F-W)
10× 4.6 0.4
100× 6.9 0.5
high-shear granulation 
with water (HS-W)
10× 4.1 0.3
100× 7.1 0.5
Spironolactone 
(SPL)
melt extrusion 10× 1.1 0.1
electrospinning 10× 1.3 0.2
Considerably lower DHIs can be seen on the melt-extruded 
and electrospun samples, thus DHI (similarly to Poole-index) 
is suitable for discriminating the advanced continuous meth-
ods from the other conventional manufacturing processes. 
However, CLMB calculations include a bias: Along this pro-
cess the pixels are used in different number of macropixels. 
For instance, the frequency of selection per pixel is shown at 
a macropixel size of 4 in Fig. 5. The pixels in the corner are 
selected one time while moving towards to inside of the map 
the frequency of selection of the pixels is increased. The high-
est bias occurs if the macropixel size is the half of the map 
size. The authors therefore recommend that weighted means 
(wDHI) should be applied in DHI calculation to avoid bias. The 
weightings are the reciprocals of corresponding frequencies.
Furthermore, the characteristics of distributions should be 
considered as well when DHI values are intended to use for 
comparing homogeneities. The DHI is a very suitable measure 
when samples come from very similar distribution as it has been 
used for controlling content uniformities of certain batches in 
an earlier paper [15]. Nevertheless the DHI is a relative value 
due to the calculation method in which the real distribution is 
compared with an artificial randomized image. Therefore, it is 
unreasonable to expect that the similar DHI values indicate sim-
ilar homogeneities while different distributions are examined. 
The method is not optimal to handle samples with strongly dif-
ferent distributions. The standard deviation of the original data, 
which includes substantial information, will be lost when real 
maps are compared to randomized images. Consequently, it is 
desirable to be calculated a corrected measure by multiplying 
the relative standard deviation (RSD) in order to avoid informa-
tion loss and to facilitate the comparison of any kind of samples, 
such as materials manufactured differently.
(4)
(6)
(5)
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Fig. 5 A part of the selection frequencies of pixels into 4×4 macropixels on a 
distribution map using CLMB method
Accordingly, the DHI values have been reconsidered. First, 
the aforementioned weighting was applied for calculations 
of mean values in Eq. (4) then the RSD of maps were taken 
into account resulting in a corrected, cDHI, value. Table 3 
summed up the results in this manner. The weighted DHIs 
(wDHI) increased significantly (comparing to the DHIs in 
Table 2) in those cases where particles or larger inhomoge-
neities are located at the edges of maps (Fig 1. c, d, f). The 
DHI of low-resolution HS-W maps decreased significantly to 
6.5 and became similar like the D (6.3) discriminating it from 
the F-W (8.0). A perfect match could be achieved between the 
cDHIs and the visual inspections. The DHIs of F-W maps were 
the highest values of all cDHIs (5.3 and 12.2 in low-resolution 
and high-resolution maps, respectively). The D maps presented 
moderately high cDHIs of 2.1 and 7.9. In contrast, values below 
1 could be achieved by HS-W technology. The homogeneity 
achieved through melt-extrusion and electrospinning exceeded 
the homogeneities provided by the conventional manufacturing 
technologies. The cDHIs were approximately 0.1 on the maps 
of melt extruded and electrospun samples. In addition the elec-
trospun SPL sample is more homogeneous than melt-extruded 
one based on corrected DHIs.
Table 3 Weighted and corrected distributional homogeneity indices (DHI) and 
relative standard deviation (RSD) in Raman distribution maps of the different 
manufactured samples
API Manufacturing technologies Objective wDHI RSD cDHI
IMP
direct compression (D)
10× 3.3 0.63 2.1
100× 6.3 1.25 7.9
fluid-bed granulation  
with water (F-W)
10× 5.4 1.01 5.3
100× 8.0 1.53 12.2
high-shear granulation 
with water (HS-W)
10× 4.5 0.18 0.8
100× 6.5 0.14 0.9
SPL
melt extrusion 10× 1.1 0.10 0.1
electrospinning 10× 1.3 0.05 0.07
4 Conclusions
Macropixel analysis can be performed in any cases when 
2dimensional distribution, such as a hyperspectral image, is 
available. This study demonstrates and underlines the need for 
novel ways to interpret the homogeneities between different 
distributions caused by manufacturing technologies in a critical 
and objective way. Two kind of macropixel analysis methodol-
ogy has been tested on the real samples, which were prepared 
by five types of manufacturing technologies including batch and 
continuous processing. Percentage of homogeneities by means 
of Poole-index (calculated from non-overlapping macropixels) 
proved to be a more sensitive measure than conventional DHI 
(created by CLMB approach) method, when detection of large 
inhomogeneity differences was required. However, it was not 
sensitive enough for discriminating the samples produced by 
continuous methods with fine inhomogeneities. Even more cru-
cially, the DLT method is a complicated and lengthy process 
due to the determination of the limited macropixel sizes. The 
CLMB approach is simpler and it requires lower calculation 
time and less computing power. Consequently, it was desirable 
to make DHI capable to describe the sample homogeneity more 
sensitively. Expecting that the DHI can be upgraded (to distin-
guish the homogeneities of similar samples properly) the use 
of weighted means and relative standard deviations of original 
datasets was included in the method. More precise measure of 
homogeneities could be achieved this way. These modifications 
enable the DHI method to compare not only similar batches but 
also maps of totally different distributions exactly in course of 
content uniformity examinations. In the future, the calculation 
of Poole-indices becomes unnecessary as the modified DHIs 
(cDHI) provide perfect description of the sample homogeneity.
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